Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations

Conclusion: The presented evidence suggests that the endocannabinoid system is a prominent target for the treatment of inflammatory and autoimmune diseases, rheumatoid diseases, viral infections, neurological and psychological pathologies, and cancer. Moreover, the antitumoral activities of CBD have been suggested to be potentially used in combination with chemo- or immunotherapy during cancer. However, clinical results are still lacking, which raises a challenge to apply translational cannabis research to the human immune system.PMID:36413346 | DOI:10.1089/can.2022.0133
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research